Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart health check: new study tests postpartum program to cut cardiovascular risk

NCT ID NCT07420465

Knowledge-focused Sponsor: Forgive Avorgbedor Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This study follows 200 pregnant women in Ghana from their third trimester through six months after birth. It measures blood pressure and artery stiffness to see if a structured education program on heart health, nutrition, and stress management can reduce long-term cardiovascular risk. The goal is to develop a scalable screening and intervention strategy for new mothers.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Postpartum Cardiovascular Disease (CVD) Risk Reduction Program (behavioral intervention)
What this could lead to
If successful, this could lead to a simple, scalable program to help new mothers lower their heart disease risk after pregnancy.
What could go wrong
This is an early-stage study with no phase, so results are preliminary. The program may not show significant improvements in blood pressure or arterial stiffness, and findings from Ghana may not apply to other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Singleton pregnancy * 18 years and older * 3rd trimester of pregnancy at enrollment * Will be living in the area for the study duration * Women with or without pregnancy complications (e.g., gestational hypertension, preeclampsia, gestational diabetes) Exclusion Criteria: * Multiple births * Diagnosed CVD or diabetes prior to pregnancy * Renal or other serious maternal diseases pre-pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiovascular disease risk are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hypertension, pregnancy-induced hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiovascular disease risk High blood pressure Hypertensive disorders of pregnancy Postpartum hypertension

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • School of Public Health

    RECRUITING

    Accra, Ghana

More trials for these conditions

Other studies related to the condition(s) this trial covers.